Late-stage Resectable Esophageal Squamous Carcinoma Clinical Trials in Luoyang, Henan

Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma